Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, announced today the
delivery of a comprehensive government and commercial recommendation to a midmarket US pharmaceutical company that prevented a yearly profit leak of $7.5 million.

The client success story is available for download here. "This pharmaceutical company was on the precipice of incurring substantial government liabilities due to a series of commercial price increases on a key product," says Edward Masterson, Senior Vice President of Consulting Operations at ALSCG. "ALSCG stepped in and provided a holistic recommendation based on optimizing regulatory policies, product distribution channels, and retail strategy."

In order to determine specific triggers and levers within the client’s contracts that were causing this issue, ALSCG developed acomprehensive model to project "what-if" scenarios illustrating the impacts of various changes in these regulatory, commercial, and contracting strategies. Healthcare reform played a significant part in how the client needed to approach ongoing participation in government programs, as well as overall contracting and retail strategies.

Through the model, ALSCG quantified the healthcare reform changes on the client’s government business segment and created new government compliance policy documents that align with healthcare reform legislation. ALSCG then provided the client with a distribution strategy that promoted regulatory compliance and long-run profitability by accounting for the client’s current people, processes, and systems.

"As healthcare reform continues to shape the industry, drug manufacturers need to be prepared to take advantage of these and other hidden opportunities at the intersection of government policy and changing market dynamics," concludes Masterson.